Bryan Johnson has dropped the medicine he had been taking for last five years. Bryan Johnson, the 47-year-old tech entrepreneur who has spent millions on his quest to reverse his biological age ...

Gabby Jones / Bloomberg / Getty Images Johnson & Johnson is scheduled to report fourth-quarter earnings Wednesday morning, with analysts expecting sales and profits to grow year-over-year.

Following a protracted search, the Chicago Bears hired former Detroit Lions offensive coordinator Ben Johnson as their next head coach. Johnson was considered arguably the single-best candidate on ...

JACKSONVILLE BEACH, Fla., January 14, 2025--(BUSINESS WIRE)--Dubin Clark is thrilled to announce two major milestones: receiving its first Small Business Investment Company (SBIC) license and ...

It’s nearly a year and a half since Johnson & Johnson split off its consumer-health arm to focus on pharmaceuticals and medical technology. Johnson & Johnson has wasted no time expanding its ...

What the government refers to as “Anomalous Health Incidents,” Havana syndrome has afflicted hundreds ... that Turner was removed as a result of Johnson’s deference to President-elect ...

Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share. Several negative impacts were highlighted in the ...

Stevens-Johnson syndrome (SJS), also called erythema multiforme major, is a systemic disease mostly involving the skin and mucous membranes. The cutaneous lesions are those of erythema multiforme ...

Diontae Johnson's 2024 odyssey has reached another twist. The Texans waived Johnson on Tuesday, the team announced. "With Diontae, unfortunately it didn't work out and we're on to the Chiefs ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...

The Diontae Johnson experiment is over in Houston. The Texans announced Tuesday they had waived the former Pro Bowl wideout ahead of their divisional-round matchup vs. the Kansas City Chiefs.

Johnson & Johnson (NYSE:JNJ) is scheduled to announce Q4 earnings results on Wednesday, January 22nd, before market open. Analysts expect a profit per share of $2.02, which is a decline of 11.8% ...